Fosravuconazole is under clinical development by Eisai and currently in Phase III for Fungal Infections. According to GlobalData, Phase III drugs for Fungal Infections have a 53% phase transition ...
Allergic bronchopulmonary aspergillosis is a pulmonary disease ... for ≥6 months off therapy with oral steroids 5a Treatment-dependent ABPA Two or more relapses within 6 months of stopping ...
Industries with workers who routinely work outdoors in the midwestern and southeastern United States should consider providing worker training and education to enhance awareness of Blastomyces, the ...
When was the last time you truly pampered your hands and feet While we often focus on facial skincare routines it easy to forget that our hands and feet deserve some love too After all they work hard ...
DELTA COUNTY, MI -- Investigators may never know the source of the fungal disease that caused the nation’s largest documented blastomycosis outbreak in a small town in Michigan’s Upper Peninsula.